Why the study?
Does L-arginine improve coronary flow and mechanical function in isolated rat hearts following cardioplegic arrest?
Does L-arginine improve coronary flow and mechanical function in isolated rat hearts following cardioplegic arrest?
Exogenous administration of L-arginine improves low coronary reflow and postischaemic mechanical function in an isolated rat heart model of cardioplegic arrest.
Answers are grounded in this paper and cite their sources.
L-arginine augments recovery in this rat model; hypothesis-generating for adjunctive use in human cardioplegia, trials needed.
OBJECTIVE: To evaluate the effect of L-arginine, the physiological substrate of nitric oxide (NO), upon coronary flow (CF) and mechanical function during reperfusion following cardioplegic arrest. METHODS: Two groups of isolated rat hearts were subjected to cardioplegic arrest for 4 h at 4 degrees C. In group 1 (n = 10) cardioplegic arrest was followed by 4 consecutive periods of reperfusion with Krebs buffer (control), Krebs plus L-lysine (1 mmol/1), Krebs plus L-arginine (1 mmol/1) and Krebs plus L-NGmonomethylarginine (L-NMMA), a specific inhibitor of NO synthesis, (0.5 mmol/1). In group 2, hearts (n = 8) were perfused by Krebs, then L-NMMA, during both pre- and postischaemic periods. In group 3, hearts (n = 8) were perfused by Krebs, then L-arginine (1, 2 and 4 mmol/1). In group 4 (n = 5), NO released into the perfusate was measured before ischaemia and during reperfusion. RESULTS: In group 1, L-arginine enhanced the postischaemic CF (ml/min +/- s.e.m.) from 15.0 +/- 0.4 to 17.2 +/-0.4. This was reduced by L-NMMA to 11.3 +/- 0.3. Postischaemic cardiac output (% of preischaemic value +/- s.e.m.) was increased from 55.8 +/- 2.4 to 80.1 +/- 2.5 by L-arginine and dropped to 54.3 +/- 2.3 with L-NMMA. In group 2, the pre- and postischaemic loss of coronary flow (CF) by L-NMMA was 51% and 31% respectively. In group 3, L-arginine did not modify CF. In group 4 the preischaemic level of NO (in nmol/ml/min) in the coronary effluent, measured by chemiluminescence, was 14.84 +/- 0.83 and dropped significantly (P < 0.05) to levels ranging from 3.80 +/- 0.56 to 4.75 +/- 0.51 during the postischaemic period. CONCLUSION: Exogenous administration of L-arginine improves low coronary reflow and postischaemic mechanical function.
No takes yet. Share an insight, caveat, or question.
Amrani et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: